Jennifer Kahn’s ‘love GMOs’ article in NYT is propaganda, not journalism
By Stacy Malkan,
U.S. Right to Know
| 07. 21. 2021
Next week in Rome, world leaders will gather to discuss how to fix the food system amid one of the worst hunger crises in recent times. According to a new United Nations report on hunger, more than 2.37 billion people did not have adequate access to food in 2020. The Covid-19 pandemic has exposed weaknesses in food systems that were already failing to meet the needs of so many people.
Rather than addressing systemic solutions for hunger and poverty, however, leaders of the upcoming UN Food Systems Summit are ignoring human rights and pushing to expand genetic engineering and commodity crop monocultures that are deepening the crises and also not feeding the world, according to hundreds of groups that are boycotting next week’s events and organizing a counter summit.
All this context is missing from a 7,000 plus word promotional article for genetically engineered foods published this week in the New York Times Magazine. Jennifer Kahn reports that, “overblown fears have turned the public against genetically modified food” even though the “potential benefits have never been greater.”...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...